...
首页> 外文期刊>Animal Pharm Weekly Briefing >US researchers developing 'superior' brucellosis vaccine, eye commercial partnerships
【24h】

US researchers developing 'superior' brucellosis vaccine, eye commercial partnerships

机译:美国研究人员开发布鲁氏菌病“优越”疫苗,眼睛的商业伙伴关系

获取原文
获取原文并翻译 | 示例
           

摘要

Researchers at the University of Florida are developing a vaccine for ruminants against brucellosis. The vaccine uses a bacterial vector to deliver multiple Brucella melitensis antigens that should enhance immunogenicity and prevent brucellosis in farm animals.B abortus infects cattle and other large ruminants, B melitensis sheep and goats, and B suis swine.Brucella infections are most prevalent in livestock in the developing world and in wildlife populations in developed countries. Brucellosis causes abortion and sterility, leading to significant industry losses. The disease also poses a threat to human health, especially in developing regions where it can be transmitted through the consumption of unpasteurized milk and milk products.
机译:佛罗里达大学的研究人员开发一种疫苗反刍动物布鲁氏菌病。提供多个布鲁氏菌melitensis抗原应加强免疫原性和防止在农场动物布鲁氏菌病。牛和其他大型反刍动物,B melitensis绵羊和山羊,和B是猪。感染是最常见的牲畜发展中国家和野生动物发达国家。与不育,导致显著的行业的损失。健康,尤其是在发展中地区可以通过消费传播的未经高温消毒的牛奶和奶制品。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号